Total Neoadjuvant Treatment

RADIATION3 trials

Sponsors

West China Hospital, The First Affiliated Hospital with Nanjing Medical University, Ain Shams University

Conditions

Biliary Tract NeoplasmsChemoradiotherapyHigh Risk FactorsLocal Advanced Rectal CancerRectal CancerTotal Neoadjuvant Treatment

Phase 2

Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC

Not yet recruitingNCT06037655

The First Affiliated Hospital with Nanjing Medical UniversityBiliary Tract Neoplasms

Start: 2023-09-25End: 2026-12-31Target: 30Updated: 2023-09-14

Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients

RecruitingNCT07095439

Ain Shams UniversityRectal Cancer

Start: 2023-09-01End: 2026-02-01Target: 38Updated: 2025-07-31

Phase 3

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

West China HospitalChemoradiotherapy, High Risk Factors, Local Advanced Rectal Cancer +1

Start: 2017-06-15End: 2023-05-30Target: 458Updated: 2018-05-08

Related Papers

Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial.

Journal of Clinical Oncology2024-06-0511 citations